US FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Retrieved on: 2021-03-04 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

US FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive .... View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.'s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® ...

Article found on: finance.yahoo.com